tiprankstipranks
Advertisement
Advertisement
Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252
PremiumThe FlySerina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252
1M ago
Serina Therapeutics initiated with a Buy at BTIG
Premium
The Fly
Serina Therapeutics initiated with a Buy at BTIG
2M ago
Serina Therapeutics Shareholders Approve Expanded Equity and Governance
Premium
Company Announcements
Serina Therapeutics Shareholders Approve Expanded Equity and Governance
2M ago
Serina Therapeutics Announces Premium Private Placement Financing
PremiumCompany AnnouncementsSerina Therapeutics Announces Premium Private Placement Financing
5M ago
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
Premium
TipRanks Newswire
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
5M ago
Serina Therapeutics names Greg Bailey co-chairman
Premium
The Fly
Serina Therapeutics names Greg Bailey co-chairman
5M ago
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
7M ago
This Is Why Serina Therapeutics Stock (SER) Rocketed Today
Premium
Market News
This Is Why Serina Therapeutics Stock (SER) Rocketed Today
7M ago
Serina Therapeutics announces FDA clearance of SER-252 new drug application
Premium
The Fly
Serina Therapeutics announces FDA clearance of SER-252 new drug application
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100